To understand the molecular mechanisms by which MsA ameliorates Alzheimer’s-related cognitive deficits, we investigated its regulatory effects on the PI3K/AKT signaling axis in N2a/APP695swe cells. The gene discussed is AKT1; the disease is Cognitive impairment.